Company / Book Value per Share
Ernexa Therapeutics Inc. Book Value per Share History
FY2014-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Book Value per Share
$0.496
FY2025
5-year range
$0.413 / $2.406
FY2021-FY2025
Trend
+20.3%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Book Value per Share has fluctuated over the past 10 years, ranging from $0.044 in FY2017 to $2.406 in FY2019.
Based on SEC 10-K filings.
$0.496 in FY2025 with a 10-year CAGR of +15.4%.
Declined from $2.361 to $0.496 over the past 2 years.
Book Value per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -22.3%
- 10-Year CAGR
- +15.4%
Key checks
Key Insights
- 5-year CAGR of -22.3%, indicating a declining trend.
- In FY2025, book value per share increased 20.3% year-over-year.
- Peak book value per share was recorded in FY2019.
- Lowest book value per share in the period was in FY2017.
Company context
Key Data Points
- Altman Z-Score -8.07 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Book Value per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.496 | +20.3% |
| FY2024 | $0.413 | -82.5% |
| FY2023 | $2.361 | +34.6% |
| FY2020 | $1.755 | -27.1% |
| FY2019 | $2.406 | +9.6% |
| FY2018 | $2.196 | +4890.0% |
| FY2017 | $0.044 | -97.9% |
| FY2016 | $2.081 | +1659.7% |
| FY2015 | $0.118 | +1.1% |
| FY2014 | $0.117 | +5.4% |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026